AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29927289 — intervention group
Group type: COMPARATOR
Intervention: Conflict marital discussion
Number of subjects: 115
Study 29927289 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure base script knowledge
Number of subjects: 115
Study 27528522 — intervention group
Group type: EXPERIMENTAL
Intervention: Multistep adaptive framework intervention in intervention ASPs
Number of subjects: 1700
Study 24643810 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-monitored group (maintaining intra-cuff pressure below 60 cm H2O)
Number of subjects: 120
Study 24643810 — intervention group
Group type: COMPARATOR
Intervention: Routine care group (control group, no further action taken)
Number of subjects: 120
Study 24643810 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study 22169620 — intervention group
Group type: EXPERIMENTAL
Intervention: Menaquinone-7 (vitamin K(2)) treatment at 45, 135, or 360 μg/d for 6 weeks
Number of subjects: 53
Study 22169620 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy age-matched individuals)
Number of subjects: 53
Study 19154562 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial intervention
Number of subjects: 1575
Study 19154562 — intervention group
Group type: EXPERIMENTAL
Intervention: Full intervention
Number of subjects: 1575
Study 19154562 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 1575
Study 18236186 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg ibandronate (1 mL) applied to the tibial bone surface 1 min before cementation
Number of subjects: 50
Study 18236186 — intervention group
Group type: COMPARATOR
Intervention: 1 mL saline applied to the tibial bone surface 1 min before cementation
Number of subjects: 50
Study 15785256 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (supervised stretching, balance, endurance, coordination, and strengthening exercises for 6 weeks)
Number of subjects: 205
Study 15785256 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 205
Study 15785256 — intervention group
Group type: COMPARATOR
Intervention: Control group (attended seminars)
Number of subjects: 205
Study 15785256 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 205
Study 12572648 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyract
Number of subjects: 23
Study 12572648 — intervention group
Group type: COMPARATOR
Intervention: Spectrum‐TPH
Number of subjects: 23
Study 12572648 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyract/TPH (sandwich)
Number of subjects: 23
Study 9448204 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 gm of ascorbic acid (vitamin C) combined with 1000 IU of d-alpha-tocopherol (vitamin E)
Number of subjects: 10
Study 9448204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 8586527 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. essential amino acids (EAA) solution 13.4 g daily + dopamine i.v. 2 micrograms/kg/min + 20% hypertonic glucose solution 500 ml/d
Number of subjects: 50
Study 8586527 — intervention group
Group type: COMPARATOR
Intervention: dopamine i.v. 2 micrograms/kg/min + 20% hypertonic glucose solution 500 ml/d
Number of subjects: 50
Study 2527048 — intervention group
Group type: EXPERIMENTAL
Intervention: glutamyl-L-dopa (gludopa)
Number of subjects: 12
Study 2527048 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 782685 — intervention group
Group type: EXPERIMENTAL
Intervention: COP (cyclophosphamide, vincristine, prednisone)
Number of subjects: 113
Study 782685 — intervention group
Group type: COMPARATOR
Intervention: CO (cyclophosphamide, vincristine)
Number of subjects: 113
Study 782685 — intervention group
Group type: EXPERIMENTAL
Intervention: COP
Number of subjects: 113
Study 782685 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended maintenance CO treatment
Number of subjects: 113
Study 31104005 — intervention group
Group type: EXPERIMENTAL
Intervention: Mulligan's mobilization with movement (MWM), exercise, and cold therapy
Number of subjects: 40
Study 31465157 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruptured cAVMs
Number of subjects: 70
Study 31465157 — intervention group
Group type: EXPERIMENTAL
Intervention: Unruptured cAVMs
Number of subjects: 70
Study 31465157 — intervention group
Group type: EXPERIMENTAL
Intervention: High-grade (SM grade) ruptured cAVMs
Number of subjects: 70
Study 31465157 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-grade (SM grade) ruptured cAVMs
Number of subjects: 70
Study 29154072 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing fresh roses for 3 minutes
Number of subjects: 15
Study 29154072 — intervention group
Group type: COMPARATOR
Intervention: No experimental stimulus (control)
Number of subjects: 15
Study 24692302 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobutrol (0.1 mmol/kg BW)
Number of subjects: 363
Study 24692302 — intervention group
Group type: COMPARATOR
Intervention: Gadopentetate dimeglumine
Number of subjects: 363
Study 23718959 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-month intervention
Number of subjects: 0
Study 21665501 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% povidone-iodine preparation with no regard to eyebrows (Group A)
Number of subjects: 77
Study 21665501 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% povidone-iodine preparation with eyebrows excluded (Group B)
Number of subjects: 77
Study 21665501 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% povidone-iodine preparation with bladed lid speculum (Group C)
Number of subjects: 77
Study 21665501 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but implied as standard preparation)
Number of subjects: 77
Study 18671796 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycaemic control (INT)
Number of subjects: 1791
Study 18671796 — intervention group
Group type: COMPARATOR
Intervention: Improved standard glycaemic control (STD)
Number of subjects: 1791
Study 16935870 — intervention group
Group type: EXPERIMENTAL
Intervention: Azimilide (125 mg o.d.)
Number of subjects: 658
Study 16935870 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 658
Study 16935870 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol (160 mg b.i.d.)
Number of subjects: 658
Study 15342288 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release niacin (3,000 mg/day)
Number of subjects: 180
Study 15342288 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release niacin (1,500 mg/day)
Number of subjects: 180
Study 15342288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 10899248 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 TU tuberculin skin test
Number of subjects: 128
Study 10899248 — intervention group
Group type: COMPARATOR
Intervention: 10 TU tuberculin skin test
Number of subjects: 128
Study 9036320 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (20 ppm)
Number of subjects: 235
Study 9036320 — intervention group
Group type: COMPARATOR
Intervention: 100% oxygen (control)
Number of subjects: 235
Study 8395712 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparins (LMWH) administered subcutaneously
Number of subjects: 0
Study 8395712 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient LMWH therapy
Number of subjects: 0
Study 8395712 — intervention group
Group type: COMPARATOR
Intervention: In-hospital care
Number of subjects: 0
Study 2868659 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha blocker (prazosin)
Number of subjects: 100
Study 2868659 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic (hydrochlorothiazide)
Number of subjects: 100
Study 2868659 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 100
Study 29363103 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined epidural-general anaesthesia (Epi-GA)
Number of subjects: 128
Study 29363103 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 128
Study 27140926 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 0
Study 27140926 — intervention group
Group type: COMPARATOR
Intervention: Zoledronic acid
Number of subjects: 0
Study 24571163 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care in Chronic Conditions Partners in Health Scale instrument
Number of subjects: 552
Study 23766350 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete revascularization (CR) with a residual SYNTAX Score of 0 (n=386, 42.7%)
Number of subjects: 903
Study 23766350 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual SYNTAX Score >0 to 4 (ICR) (n=184, 20.4%)
Number of subjects: 903
Study 23766350 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual SYNTAX Score >4 to 8 (ICR) (n=167, 18.5%)
Number of subjects: 903
Study 23766350 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual SYNTAX Score >8 (ICR) (n=153, 16.9%)
Number of subjects: 903
Study 20925605 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline wound irrigation before wound closure
Number of subjects: 520
Study 20925605 — intervention group
Group type: COMPARATOR
Intervention: No saline wound irrigation (Control)
Number of subjects: 520
Study 18979587 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous gluconate (FG)
Number of subjects: 0
Study 18979587 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulfate (FS)
Number of subjects: 0
Study 18979587 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study 16521637 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose atorvastatin (10 mg)
Number of subjects: 150
Study 16521637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 12698315 — intervention group
Group type: EXPERIMENTAL
Intervention: Water (750 ml)
Number of subjects: 19
Study 12698315 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (750 ml)
Number of subjects: 19
Study 10491472 — intervention group
Group type: EXPERIMENTAL
Intervention: Epley maneuver
Number of subjects: 4
Study 10491472 — intervention group
Group type: EXPERIMENTAL
Intervention: Semont maneuver
Number of subjects: 4
Study 10491472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 8736053 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhinomer (cleansing preparation of isotonic, sterile, undiluted sea water)
Number of subjects: 28
Study 8736053 — intervention group
Group type: COMPARATOR
Intervention: Prorhinel (marketed solution containing an antiseptic agent)
Number of subjects: 28
Study 1928767 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (5 micrograms/kg infused the 1st hour and then 0.3 microgram-1.kg-1.h-1 during 11 hours)
Number of subjects: 50
Study 1928767 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 7121093 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized telephone service
Number of subjects: 561
Study 7121093 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 561
Study 30095158 — intervention group
Group type: EXPERIMENTAL
Intervention: MCL35 gene expression proliferation assay
Number of subjects: 0
Study 30095158 — intervention group
Group type: COMPARATOR
Intervention: Ki‐67 index
Number of subjects: 0
Study 30095158 — intervention group
Group type: COMPARATOR
Intervention: MIPI
Number of subjects: 0
Study 28424068 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdiagnostic Internet‐based protocol (TIBP)
Number of subjects: 207
Study 28424068 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdiagnostic Internet‐based protocol + positive affect component (TIBP + PA)
Number of subjects: 207
Study 28424068 — intervention group
Group type: COMPARATOR
Intervention: Waiting List control group (WL)
Number of subjects: 207
Study 26026580 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramelteon (8 mg nightly for 3 weeks)
Number of subjects: 13
Study 26026580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 24411681 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy during labor
Number of subjects: 161
Study 24411681 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 161
Study 21103989 — intervention group
Group type: EXPERIMENTAL
Intervention: 35-g/m2 titanized polypropylene mesh (Group A)
Number of subjects: 380
Study 21103989 — intervention group
Group type: COMPARATOR
Intervention: 16-g/m2 titanized polypropylene mesh (Group B)
Number of subjects: 380
Study 19116896 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate 4.5 gm
Number of subjects: 188
Study 19116896 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate 6 gm
Number of subjects: 188
Study 19116896 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study 19116896 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate (both dosages)
Number of subjects: 188
Study 18612886 — intervention group
Group type: EXPERIMENTAL
Intervention: Illicit methadone use in the past month
Number of subjects: 383
Study 18612886 — intervention group
Group type: EXPERIMENTAL
Intervention: History of regular illicit methadone use
Number of subjects: 383
Study 18612886 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger age and history of outpatient psychological treatment
Number of subjects: 383
Study 15820760 — intervention group
Group type: EXPERIMENTAL
Intervention: O-[11C]methyl-L-tyrosine
Number of subjects: 0
Study 12076342 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise training (EX) for 30‐60 min three to five times a week at 40‐60% of maximal oxygen consumption
Number of subjects: 112
Study 12076342 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise training (EX)
Number of subjects: 112
Study 12076342 — intervention group
Group type: COMPARATOR
Intervention: Control group (CO)
Number of subjects: 112
Study 10208495 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E 1000 IU/day
Number of subjects: 20
Study 7797807 — intervention group
Group type: EXPERIMENTAL
Intervention: High vegetable/fruit diet
Number of subjects: 10
Study 7797807 — intervention group
Group type: EXPERIMENTAL
Intervention: Legume/allium diet (containing garbanzo beans, garlic, and onions)
Number of subjects: 10
Study 7797807 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet
Number of subjects: 10
Study 7797807 — intervention group
Group type: EXPERIMENTAL
Intervention: Legume/allium diet
Number of subjects: 10
Study 7797807 — intervention group
Group type: COMPARATOR
Intervention: Controlled basal diet
Number of subjects: 10
Study 2128094 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (170 micrograms/min)
Number of subjects: 22
Study 2128094 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentolamine (1-1.5 mg/min)
Number of subjects: 22
Study 368087 — intervention group
Group type: EXPERIMENTAL
Intervention: Maprotiline
Number of subjects: 341
Study 368087 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 341
Study 30808625 — intervention group
Group type: EXPERIMENTAL
Intervention: golimumab (50 mg SC monthly) + MTX (n=26)
Number of subjects: 51
Study 30808625 — intervention group
Group type: COMPARATOR
Intervention: placebo + MTX (n=25)
Number of subjects: 51
Study 28411697 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovenous cyanoacrylate closure (CAC)
Number of subjects: 222
Study 28411697 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 222
Study 25424398 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) - 16 weekly sessions
Number of subjects: 31
Study 25424398 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 31
Study 25424398 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 31
Study 23587190 — intervention group
Group type: EXPERIMENTAL
Intervention: 35,000 IU/week of vitamin D3
Number of subjects: 160
Study 23587190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 21340544 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium elastic nailing (TEN)
Number of subjects: 46
Study 21340544 — intervention group
Group type: COMPARATOR
Intervention: Hip spica cast
Number of subjects: 46
Study 18440534 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1700 mg/day for 6 months)
Number of subjects: 80
Study 18440534 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate (CC) (50 mg/day, increasing doses up to 250 mg/day)
Number of subjects: 80
Study 17366011 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam 18/9 g daily dose (group A)
Number of subjects: 27
Study 17366011 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam 24/12 g daily dose (group B)
Number of subjects: 27
Study 17366011 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam (both groups)
Number of subjects: 27
Study 14715352 — intervention group
Group type: COMPARATOR
Intervention: HRT
Number of subjects: 16
Study 14715352 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT + simvastatin
Number of subjects: 16
Study 11386264 — intervention group
Group type: EXPERIMENTAL
Intervention: Bucindolol
Number of subjects: 2708
Study 11386264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2708
Study 9140570 — intervention group
Group type: EXPERIMENTAL
Intervention: 29-item self-report inventory for screening major mental disorders
Number of subjects: 483
Study 9140570 — intervention group
Group type: COMPARATOR
Intervention: 46-item inventory (initial version)
Number of subjects: 483
Study 8173851 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone succinate (HC)
Number of subjects: 300
Study 8173851 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TA)
Number of subjects: 300
Study 8173851 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone hexacetonide (TH)
Number of subjects: 300
Study 2906477 — intervention group
Group type: EXPERIMENTAL
Intervention: Olsalazine, 500 mg b.d.
Number of subjects: 82
Study 2906477 — intervention group
Group type: COMPARATOR
Intervention: Sulphasalazine, 1 g b.d.
Number of subjects: 82
Study 29685343 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabazitaxel Q1W, 10 mg/m2
Number of subjects: 101
Study 29685343 — intervention group
Group type: COMPARATOR
Intervention: Cabazitaxel Q3W, 25 mg/m2
Number of subjects: 101
Study 28093636 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock wave therapy
Number of subjects: 143
Study 28093636 — intervention group
Group type: COMPARATOR
Intervention: No shock wave therapy (control group)
Number of subjects: 143
Study 26268930 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation program (aerobic training for 35 minutes at 60-80% intensity, strength training for quadriceps, biceps, and deltoids at 40-70% intensity, and use of Flutter® device for 5 minutes)
Number of subjects: 0
Study 26268930 — intervention group
Group type: COMPARATOR
Intervention: Chest physiotherapy + stretching exercises (control group)
Number of subjects: 0
Study 23640324 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar extension traction in addition to stretching exercises and infrared radiation
Number of subjects: 80
Study 23640324 — intervention group
Group type: COMPARATOR
Intervention: Stretching exercises and infrared radiation (Control)
Number of subjects: 80
Study 21356013 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbead dentifrice
Number of subjects: 22
Study 18711387 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-session behavioral weight loss program (first-time participants)
Number of subjects: 2808
Study 18711387 — intervention group
Group type: COMPARATOR
Intervention: 16-session behavioral weight loss program (repeat participants)
Number of subjects: 2808
Study 16770092 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab (Herceptin)
Number of subjects: 0
Study 16770092 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab with paclitaxel
Number of subjects: 0
Study 14597939 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin-strut stent (n = 326)
Number of subjects: 651
Study 14597939 — intervention group
Group type: COMPARATOR
Intervention: Thick-strut stent (n = 325)
Number of subjects: 651
Study 10983676 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (1 g)
Number of subjects: 27
Study 10983676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 8703453 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous cuff pressure monitoring (Group 2)
Number of subjects: 200
Study 8703453 — intervention group
Group type: COMPARATOR
Intervention: Standard cuff pressure monitoring (Group 1)
Number of subjects: 200
Study 1558834 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg/day for 10 days)
Number of subjects: 6
Study 3911365 — intervention group
Group type: EXPERIMENTAL
Intervention: Antacid group (4 chewable aluminum-magnesium-antacid tablets daily)
Number of subjects: 80
Study 3911365 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 80
Study 3911365 — intervention group
Group type: EXPERIMENTAL
Intervention: Antacid group
Number of subjects: 80
Study 31944472 — intervention group
Group type: EXPERIMENTAL
Intervention: 18-month weight management intervention (reduced calorie diet, 150 min of moderate-vigorous intensity physical activity per week, daily dietary logging, monthly at-home visits by a health educator)
Number of subjects: 124
Study 31944472 — intervention group
Group type: EXPERIMENTAL
Intervention: 18-month weight management intervention
Number of subjects: 124
Study 28981834 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep loss condition (restricted to 4 h sleep for 3 nights)
Number of subjects: 68
Study 28981834 — intervention group
Group type: COMPARATOR
Intervention: Control condition (standard sleep)
Number of subjects: 68
Study 28981834 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep loss condition
Number of subjects: 68
Study 27906919 — intervention group
Group type: EXPERIMENTAL
Intervention: Scratch test
Number of subjects: 50
Study 27906919 — intervention group
Group type: COMPARATOR
Intervention: Percussion test
Number of subjects: 50
Study 27906919 — intervention group
Group type: EXPERIMENTAL
Intervention: Scratch test (young trainees)
Number of subjects: 50
Study 27906919 — intervention group
Group type: COMPARATOR
Intervention: Percussion test (young trainees)
Number of subjects: 50